搜索筛选:
搜索耗时0.0896秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
类      型:
[会议论文] 作者:Cheng Kong,Xiang-zhi Zhu,Ping-bo Feng,Jian-hua Xu,Pu-dong Qian,Lan-fang Zhang,Xia He,Sheng-fu Huang,Yi-qin, 来源:中华医学会第十二次全国放射肿瘤学治疗学学术会议 年份:2015
[会议论文] 作者:Cheng Kong,Xiang-zhi Zhu,Ping-bo Feng,Jian-hua Xu,Pu-dong Qian,Lan-fang Zhang,Xia He,Sheng-fu Huang,Yi-qin, 来源:第七届全国鼻咽癌学术大会 年份:2015
Purpose:To assess the temporal lobe injury(TLI) after intensity modulated radiotherapy(IMRT) for nasopharyngeal carcinoma(NPC) and to explore the predictors and tolerance dose (TD) for the development...
[会议论文] 作者:Cheng Kong,Xiang-zhi Zhu,Ping-bo Feng,Jian-hua Xu,Pu-dong Qian,Lan-fang Zhang,Xia He,Sheng-fu Huang,Yi-qin, 来源:中华医学会第十二次全国放射肿瘤学治疗学学术会议 年份:2015
Background The purpose of this study was to assess temporal lobe injury (TLI) after intensity modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC) and to explore the dosimetric predictors...
[会议论文] 作者:Xue Meng,Jin-Ming Yu,Xin-Dong Sun,Shu-Chai Zhu,Chun Han,Jian-Hua Wang,Lv-Hua Wang,Ming Ye,Ping-Bo Feng, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
[会议论文] 作者:Xue Meng,Shu-Chai Zhu,Jin-Ming Yu,Jian-Hua Wang,Xin-Dong Sun,Lv-Hua Wang,Ming Ye,Ping-Bo Feng,Guang-Ying, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
Objectives: To investigate cetuximab added to concurrent chemoradiotherapy for Chinese patients with locally advanced esophageal squamous cell carcinoma (ESCC).Methods: Eligible patients with non-rese...
相关搜索: